Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Journal of Health Economics|December 7, 2013
Pharmaceutical advertising and Medicare Part DDarius Lakdawalla, Neeraj Sood, Qian GuJournal of Health Economics|May 13, 2014
Are investments in disease prevention complements? The case of statins and health behaviorsRobert Kaestner, Michael Darden, Darius LakdawallaJournal of Public Economics|June 5, 2023
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part DAbby Alpert, Darius Lakdawalla, Neeraj SoodThe American Journal of Clinical Nutrition|July 9, 2005
Government perspective: food labelingTomas PhilipsonJournal of Public Economics|May 2, 2025
Health Risk and the Value of LifeDaniel Bauer, Darius Lakdawalla, Julian ReifThe American Journal of Managed Care|December 27, 2018
Cost variation and savings opportunities in the Oncology Care ModelJames Baumgardner, Ahva Shahabi, Christopher Zacker, et al.The New England Journal of Medicine|August 19, 2011
Malpractice risk according to physician specialtyAnupam B Jena, Seth Seabury, Darius Lakdawalla, et al.Annals of Internal Medicine|September 20, 2021
Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation StudyJulian Reif, Hanke Heun-Johnson, Bryan Tysinger, et al.Medical Care|June 11, 2020
Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal DialysisEugene Lin, Glenn M Chertow, Jay Bhattacharya, et al.Health Affairs (Project Hope)|May 9, 2007
Cost-effectiveness as a price controlAnupam B Jena, Tomas PhilipsonPageof 6